Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy - 05/11/12
, Wei Zhao, Yan-Dan Zhong
Corresponding author. Tel.: +86 025 83626433; fax: +86 028 83626433.Summary |
We reported a case of Hepatitis B virus-related membranous nephropathy (HBV-MN) with improvement under an ongoing 4.5-year of entecavir monotherapy. A 37years old man with a 5years’ history of chronic hepatitis B (CHB) who was taken to our department because of proteinuria and microscopic haematuria. A renal biopsy led to a diagnosis of HBV-MN with mesangioproliferative. Interferon-alpha 2b (IFN-⍺2b) was stopped after 24weeks due to the increasement of HBV-DNA and sustained HBeAg positive. Therefore, we started using 0.5mg entecavir per day. After 2months’ treatment, HBV-DNA was not detected in the blood, and the ALT and AST decreased to normal degree. After 3years of entecavir therapy, virological tests revealed HBeAg seroconversion. With no further intervention during the next one and a half years, there was improvement of proteinuria gradually. This suggested that entecavir monotherapy may induce and maintain complete remission of membranous nephropathy associated with hepatitis B.
Le texte complet de cet article est disponible en PDF.Plan
Vol 36 - N° 5
P. e89-e92 - octobre 2012 Retour au numéro
Article précédent
- Etifoxine-induced acute hepatitis: A case series
- Céline Moch, Fanny Rocher, Pascale Lainé, Jacqueline Lacotte, Michel Biour, Aurore Gouraud, Nathalie Bernard, Jacques Descotes, Thierry Vial
- Peribiliary cysts mistaken for a biliary dilatation in a cirrhosis patient
- Pierre François Montoriol, Laurent Poincloux, Virginie Petitcolin, David Da Ines
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?